BDX Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 май 2024 @ 23:00):

Stats
Объем за сегодня	1.39M
Средний объем	1.36M
Рыночная капитализация	67.80B
EPS	$0 ( 2024-05-02 )
Дата следующего отчета о доходах	( $3.38 ) 2024-08-01
Last Dividend	$0.950 ( 2024-03-07 )
Next Dividend	$0 ( N/A )
P/E	50.36
ATR14	$0.164 (0.07%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-30	Garrison Michael David	Sell	1 715	Common Stock
2024-04-04	Neal Shana Carol	Sell	1 921	Common Stock
2024-03-14	Spoerel Thomas J	Sell	282	Common Stock
2024-03-01	Garrison Michael David	Sell	178	Common Stock
2024-03-01	Spoerel Thomas J	Sell	36	Common Stock

INSIDER POWER
68.13
Last 100 transactions
Buy: 255 635 \| Sell: 56 729

Объем Корреляция

Длинно: -0.62 (weak negative)

Кратко: -0.67 (moderate negative)

Signal:(25.906) Neutral

Becton Dickinson and Co Корреляция

10 Самые положительные корреляции
AGQ	0.901
SLV	0.889
SIVR	0.888
PSLV	0.881
SO	0.88
KMB	0.88
LLY	0.864
TDI	0.855
NVS	0.853
PG	0.833

10 Самые отрицательные корреляции
ZSL	-0.861
INSW	-0.854
AYI	-0.853
NM	-0.838
TNP	-0.83
STAR	-0.827
TEX	-0.823

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Becton Dickinson and Co Корреляция - Валюта/Сырье

0.57
( weak )

0.35
( neutral )

0.00
( neutral )

0.46
( neutral )

0.29
( neutral )

-0.23
( neutral )

Becton Dickinson and Co Финансовые показатели

Annual	2023
Выручка:	$19.37B
Валовая прибыль:	$8.17B (42.17 %)
EPS:	$4.97

FY	2023
Выручка:	$19.37B
Валовая прибыль:	$8.17B (42.17 %)
EPS:	$4.97

FY	2022
Выручка:	$18.87B
Валовая прибыль:	$8.48B (44.92 %)
EPS:	$5.93

FY	2021
Выручка:	$20.25B
Валовая прибыль:	$9.43B (46.56 %)
EPS:	$6.92

Financial Reports:

No articles found.

Becton Dickinson and Co Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.870 (N/A)	$0.910 (N/A)	$0.910 (N/A)	$0.910 (N/A)	$0.910 (N/A)	$0.950 (N/A)	$0.950 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Becton Dickinson and Co Dividend Information - Dividend Knight

Dividend Sustainability Score: 8.57 - good (85.74%) | Divividend Growth Potential Score: 4.28 - Stable (14.41%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0213	1973-02-28
Last Dividend	$0.950	2024-03-07
Next Dividend	$0	N/A
Payout Date	2024-03-29
Next Payout Date	N/A
# dividends	165	--
Total Paid Out	$47.51	--
Avg. Dividend % Per Year	1.05%	--
Score	4.85	--
Div. Sustainability Score	8.57
Div.Growth Potential Score	4.28
Div. Directional Score	6.43	--

Next Divdend (Est)
(2024-05-06)

$0.960 Estimate 60.01 %

Dividend Stability

0.96 Excellent

Dividend Score

4.85

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
1973	$0.0213	0.94%
1974	$0	0.00%
1975	$0	0.00%
1976	$0	0.00%
1977	$0	0.00%
1978	$0	0.00%
1979	$0	0.00%
1980	$0	0.00%
1981	$0	0.00%
1982	$0	0.00%
1983	$0.0525	2.00%
1984	$0.0716	3.11%
1985	$0.0750	3.10%
1986	$0.0829	2.18%
1987	$0.0940	1.52%
1988	$0.109	1.74%
1989	$0.124	1.99%
1990	$0.134	1.76%
1991	$0.143	1.57%
1992	$0.150	1.85%
1993	$0.166	1.75%
1994	$0.187	2.13%
1995	$0.210	1.78%
1996	$0.232	1.25%
1997	$0.229	1.08%
1998	$0.295	1.21%
1999	$0.339	0.81%
2000	$0.365	1.43%
2001	$0.374	1.12%
2002	$0.384	1.18%
2003	$0.439	1.43%
2004	$0.614	1.53%
2005	$0.738	1.35%
2006	$0.869	1.47%
2007	$0.995	1.45%
2008	$1.156	1.37%
2009	$1.327	1.95%
2010	$1.493	1.95%
2011	$1.669	2.02%
2012	$1.800	2.48%
2013	$1.981	2.56%
2014	$2.18	2.05%
2015	$2.40	1.76%
2016	$2.64	1.83%
2017	$2.87	1.78%
2018	$2.95	1.39%
2019	$3.02	1.41%
2020	$3.12	1.17%
2021	$3.28	1.34%
2022	$3.50	1.42%
2023	$3.68	1.44%
2024	$0.950	0.39%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
PCF	Dividend King	2023-12-18	Monthly	38	7.05%	8.50
ZTR	Dividend Royal	2024-02-09	Monthly	37	8.35%	8.50
PVL	Dividend King	2023-11-15	Monthly	14	9.37%	8.50
JQC	Dividend Royal	2023-11-14	Monthly	22	6.56%	8.50
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
SBR	Dividend Royal	2023-11-14	Monthly	38	7.74%	8.50
SCM	Dividend King	2023-12-15	Monthly	13	7.08%	8.50
MTR	Dividend Diamond	2023-10-30	Monthly	39	10.10%	8.50
PDI	Dividend Royal	2023-11-10	Monthly	13	7.86%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0676	1.500	8.65	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0246	1.200	9.18	10.00	[0 - 0.3]
returnOnEquityTTM	0.0519	1.500	-0.534	-0.801	[0.1 - 1]
payoutRatioTTM	0.826	-1.000	1.740	-1.740	[0 - 1]
currentRatioTTM	1.411	0.800	7.94	6.36	[1 - 3]
quickRatioTTM	0.789	0.800	-0.0655	-0.0524	[0.8 - 2.5]
cashRatioTTM	0.327	1.500	9.30	10.00	[0.2 - 2]
debtRatioTTM	0.333	-1.500	4.46	-6.69	[0 - 0.6]
interestCoverageTTM	-724.00	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	12.99	2.00	5.67	10.00	[0 - 30]
freeCashFlowPerShareTTM	10.45	2.00	4.77	9.55	[0 - 20]
debtEquityRatioTTM	0.702	-1.500	7.19	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.412	1.000	6.46	6.46	[0.2 - 0.8]
operatingProfitMarginTTM	0.110	1.000	9.80	9.80	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.209	1.000	9.95	9.95	[0.2 - 2]
assetTurnoverTTM	0.364	0.800	-0.906	-0.725	[0.5 - 2]
Total Score				8.57

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	50.97	1.000	4.95	0	[1 - 100]
returnOnEquityTTM	0.0519	2.50	-0.343	-0.801	[0.1 - 1.5]
freeCashFlowPerShareTTM	10.45	2.00	6.52	9.55	[0 - 30]
dividendYielPercentageTTM	1.585	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	12.99	2.00	5.67	10.00	[0 - 30]
payoutRatioTTM	0.826	1.500	1.740	-1.740	[0 - 1]
pegRatioTTM	0.336	1.500	-1.092	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.191	1.000	7.73	0	[0.1 - 0.5]
Total Score				4.28

Becton Dickinson and Co

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.